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Chapter 1. Introduction 
1.1 Biomaterials 
A biomaterial is defined as “any material, natural or man-made, that comprises 
whole or part of a living structure or biomedical device which performs, augments, or  
Figure 1-1.  Examples of biomaterials in a variety of applications. 
replaces a natural function.
8
  Biomaterials may be used to make devices such as hip 
replacement joints (Figure 1a) using metals and plastics, finger replacement joints (Figure 
1b) using silicone polymers, and drug delivery implants (Figure 1c) using encapsulated 
hydrogels.  Other applications include tooth orthodontics (Figure 1d) using metal, resin 
and rubber, and synthetic skin grafts (figure 1e) composed of hydrophilic polymers, as 
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well as active devices, stents, and sutures.
9
    Many types of materials have been 
investigated for use as biomaterials.  Among them, polymers are a versatile class of 
materials that are particularly attractive as biomaterials; the flexibility in their synthesis 
and modification has prompted the extensive investigation of polymers in biomedical 
contexts. 
1.2 Polymers as Biomaterials 
When synthetic polymers were first used as biomaterials, they were limited to 
polymers that had been made for other applications.
9
  However, in the last sixty years, 
materials scientists have begun synthesizing novel polymers specifically for use in 
biomedical applications.  These materials are tuned to be biocompatible and exhibit 
suitable mechanical properties for their specific biomedical applications.  Examples of 
commonly used polymeric biomaterials include poly(lactide), poly(glycolide), their 
copolymers and poly(caprolactone). 
1.3 Degradable Biomaterials 
Recent advances in pharmaceutical science and biotechnology have lead to a 
demand for materials that degrade over time in addition to being biocompatible.  
Biodegradable materials are well-suited to in vivo applications, such as tissue scaffolds or 
implanted drugs.  The use of biostable polymers in these applications often requires a 
second surgical procedure to remove the polymers to avoid long-term biocompatibility 
issues.
9
  Biodegradable polymers are those which degrade into either normal metabolites 
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of the body or into products that can be completely eliminated by the body.  Because 
these materials biodegrade over a period of time, they have the advantage of transferring 
load slowly to tissue in orthopedic applications.
9
  For drug delivery applications, tuning 
the degradation rate of the carrier polymer can achieve a more dynamic range of drug 
release which may lead to better control of therapeutic levels of a drug.  In all cases, the 
versatility of synthetic polymers gives them an enormous advantage over natural 
polymers.  Synthetic polymers can be made with desired properties with a high degree of 
reproducibility.  One key property that can be manipulated is their rate of degradation, 
making them excellent candidates for biodegradable materials. 
1.4 Common Degradation Mechanisms and Control 
Polymers that are used in biomedical applications generally degrade in vivo by one of two 
methods: hydrolysis or oxidation.
10
  In polymers with hydrolytically unstable functional 
groups in the backbone such as, poly(esters) and poly(anhydrides), hydrolysis is the 
predominanmechanism of degradation.  Other commonly used materials, such as 
poly(ethers), poly(urethanes) and poly(ureas), are hydrolytically stable at biological pH 
and degrade primarily by oxidation mechanisms.
10
  In some cases, the polymer is initially 
oxidized by reactive oxygen species produced by enzymes that are secreted by 
macrophages adhered to the material surface.  The resulting ester bonds are then 
degraded by hydrolysis.
11
  Even substances made from materials that are considered  
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Table 1-1. Hydrolysis Half lifes of Common Degradable Polymers. 
General Polymer Half-Life of Hydrolysis 
Polyamide 60 years
12
 
Polycarbonate 54 years
13
 
Polyurethane 33 years
12
 
Polyacetal 24 months
14
 
Polylactide 8 months
15
 
Polyphosphoester 6 days
13
 
Polyorthoester 4 hours
14
 
Polyketal 3 hours
14
 
Polyanhydride 6 minutes
14
 
Polyphosphazene 15 seconds
16
 
relatively inert, such as poly(tetrafluroethylene) (PTFE), have been shown to degrade 
oxidatively to particles over a period of 2 to 3 years.
17
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Hydrolytic degradation is a fast process (table 1-1), relative to oxidative degradation. The 
hydrolytic stability of polymers is dependent on many variables.  These may include 
chemical composition and sequence structure (as it relates to tacticity), molecular weight 
and polydispersity, morphology, porosity of the sample, thermal properties, additives and 
impurities (molecules absorbed from the media), environmental conditions (ionic 
strength, temperature and pH), and stress and strain during degradation.
1
  Hydrolysis 
occurs in two different ways: bulk degradation and surface erosion (figure 1-2).  Both of 
these mechanisms are idealized, and in practice, some aspects of each can often be 
observed.
18
  In bulk degradation, water is absorbed by the material, and degradation takes 
place throughout the material.  This type of degradation is predominant in poly(esters), 
such as poly(lactide) and poly(glycolide) and their copolymers.
19
  In contrast, surface 
eroding polymers are those that do not take up water, but have hydrolytically unstable 
bonds in the backbone.  Because of this, degradation is limited to the surface of the 
material and is characterized by linear mass loss of a material during degradation.
20
  
Polymers such as poly(anhydrides) and poly(orthoesters) are reported to undergo surface 
erosion degradation.  Factors influencing which type of degradation is observed include 
the hydrophilicity/hydrophobicity, crystallinity and the sample size.
21
  Increased 
hydrophobicity and crystallinity limit water penetration into the matrix and decrease the 
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Surface Erosion 
Degree of Degradation 
 
Figure 1-2.  Schematic illustration of idealized types of hydrolytic degradation.
1
  
amount of bulk degradation observed.  Degradation properties of a material can be tuned 
by changing the hydrophobicity/ hydrophilicity of the material.  An example is initiating 
polymerizations of poly(glycolide) or poly(lactide) with monomethoxy poly(ethylene 
glycol)  of different molecular weights.
22
  Increasing the amount of the hydrophilic 
poly(ethylene glycol) unit increases water penetration and, therefore, the rate of 
degradation. 
1.4.1 Cleavage Locations 
An intentionally degradable polymer is one that has cleavable groups within its 
structure, but the placement of these groups with the polymer architecture can have 
differing effects, that match their intended applications.  Cleavable sites can generally be 
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inserted into polymers in three different places: in the polymer backbone, in crosslinks, or 
on side chains.
23
 
1.4.1.1 Backbone 
Placement of degradable units in a polymer backbone yields a material that upon 
degradation results in polymer chains with lower molecular weights progressively until, 
generally, the fragments are soluble (figure 1-3).  This is the common architecture for a 
sizable amount of the biodegradable polymers currently used in biotechnology.  Since 
mosbiotechnological applications of these materials are in aqueous environments, water 
 
Figure 1-3. Degradation of a polymeric material along its backbone, yielding smaller, 
soluble fragments. 
is usually either the trigger that initiates degradation, or the medium by which the trigger 
is introduced to the material.  As degradation occurs, chain molecular weight decreases, 
and water swells the polymer matrix.  This allows for smaller fragments to be released, 
lowering the mass, and changing the material’s physical and chemical properties. 
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Polymers are most commonly used in structural applications such as degradable 
clips, screws, plates and sutures, as well as materials used for drug delivery.  These 
polymers usually degrade hydrolytically, and often contain a degradable functional group 
that is listed in figure 1-4 below.  The general hydrolytic half-lives of these types of 
polymers are listed in table 1-1.  To synthesize materials with appropriate degradation 
profiles for specific applications, selection of a system with an appropriate hydrolytic 
half-life is required.  For instance, a polyanhydride material is likely to decompose on the 
order of days
24
, whereas a polyester material will likely degrade on the order of months
25
. 
Figure 1-4.  Common functional groups susceptible to hydrolysis. 
Within materials using the same functional group, degradation rates can be 
manipulated by varying the amount of crystallinity in a material.  Crystalline materials 
will generally degrade slower than amorphous materials.
26
  An example of this is that 
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poly(L-lactide) degrades more slowly than poly(D,L-lactide) because the more 
stereoregular poly(L-lactide) crystallizes more efficiently.
27
  The crystallinity limits the 
access of water into the material, thus reducing the rate of degradation.  This can also be 
observed when comparing the half-lives of hydrolysis between homopolymers of poly(L-
lactide), poly(glycolide) and the copolymers of various compositions of the two (figure 1-
5).  As expected, any significant presence of one of the two components in the presence 
of the other reduces crystallinity, and increases the rate of hydrolysis, as illustrated in 
figure 1-5.
2
. 
 
Figure 1-5.  The effect of composition on the rate of hydrolysis in PLA/PGA 
copolymers
2
. 
This same effect can be achieved by using a material that is more hydrophobic, 
and thus reduce the amount of water available in the material to participate in hydrolysis. 
An example is the common polyethylene terephthalate, which is used in the manufacture 
10 
 
of water bottles.  Though this polymer is hydrolytically degradable polyester, if it were 
readily hydrolyzed, it would not be suitable for one of its most common applications. 
1.4.1.2 Cross Linkers 
Another location in which to install degradable functionality is in polymer crosslinks.  
Crosslinks are molecules or bonds that serve to link one polymer chain to another.  This 
allows for some interesting possibilities in materials such as elastomers, adhesives, 
coatings and hydrogels.  Since many important physical properties are dependent on the 
number of crosslinks in the material
28
, being able degrade crosslinks specifically allows 
the physical properties of a crosslinked material to be changed while the material is in 
use.  Degradable crosslinks can be used to synthesize degradable adhesives and resins.  A 
potential application of a degradable crosslinker is as a dimethacrylate crosslinking agent.  
Dimethacrylate compounds are common crosslinking reagents used in dental adhesives 
and composites.  These compounds (figure 1-6) include triethylene glycol dimethacrylate 
(TEGDMA)(1), bisphenol A-glycidal methacrylate (BIS-GMA) (2) and urethane 
dimethacrylate (UDMA) (3).
7
  These dimethacrylate compounds are often copolymerized 
with methacrylate ester monomers such as hydroxyethyl methacrylate (HEMA).  HEMA 
is an important component of dental adhesive composites because it is hydrophilic 
enough to infiltrate and bond to wet dentin.
29
  These adhesives are used in applications 
such as bonding braces to teeth.  The monomers and a photo-initiator are formulated into 
11 
 
a paste, put into position and irradiated with light to polymerize the 
 
Figure1-6.  Common crosslinking agents in dental composites. 
material in place.  When removing braces from a patient, it is common for some polymer 
to remain adhered to teeth.  This residual polymer is typically removed by grinding it off 
of the teeth.  For patients with sensitive teeth, this process can be excruciatingly painful.  
To avoid this, the crosslinking agents could be replaced with degradable analogs.  
Incorporation of such a compound would allow the crosslinks of the network solid 
adhesive to be degraded and the resin adhesive removed relatively pain free. 
Another potential area of interest for the use of degradable crosslinkers is in 
hydrogels.  Hydrogels are hydrophilic polymers that are crosslinked to prevent 
12 
 
dissolution in water.  This results in a network material that will swell greatly in water 
and often a hydrogel will absorb enough water that a swollen hydrogel is more than 90 % 
water.  The high water content and hydrophilic nature of the polymers results in a 
material that generally has good biocompatibility.
30
  In a hydrogel system, degradation of 
crosslinks result in soluble polymer chains, leading to the material dissolving and 
diffusing away (figure 1-7). 
 
 
Figure 1-7.  Degradation of crosslinks to give soluble polymer chains. 
The porous nature and high percentage of water make hydrogels favorable for 
tissue engineering and cell culture applications.  Hydrogels can provide a physical 
scaffold for cells and tissues, while still allowing transport of nutrients in, and waste out.  
In cell culture applications, a hydrogel acts as a 3D culture media, and acts as an analog 
of the extracellular matrix of more mature cells, and has similar physical and biochemical 
characteristics of many biological systems.  Hydrogels have been shown to have the 
13 
 
ability to support the growth of cells, and afford a sustained release of bioactive 
molecules.
31
 
Some of the most commonly used polymers for hydrogels include poly(ethylene 
glycol),
4
 poly(hydroxyethyl methacrylate),
32-34
 hyaluronic acid,
35
 poly(vinyl alcohol),
36
 
and alginate.
37
  Selection of hydrophilic polymer, and their crosslink composition is the 
primary way in which to control the degradation rate of degradable hydrogels. 
1.4.1.3 Side-chains 
An alternative approach to adding degradable functionality is to place it on side 
chains of a polymer.  This is usually done to change the physical properties of the 
polymer when degraded, or so that degradation releases a therapeutic agent (figure 1-8).
38
  
A common application is with copolymers of maleic anhydride as a coating for tablets to 
 
 
Figure 1-8. Degradation in polymer sidechains to either release therapeutic payload, or 
change the physical properties of a polymer. 
target a pharmaceutical to be released in the intestines.
39
  Such coatings are hydrophobic 
when in the form of the anhydride, but hydrolyzed to carboxylic acids in the acidic 
14 
 
environment of the stomach.  Once the polymers reach the higher pH of the intestines, the 
carboxylic acids ionize, making the coating now hydrophilic, allowing water to penetrate 
and release the therapeutic agent. 
1.4.2 Triggering Degradation 
The characteristic that makes a polymer degradable is the presence of cleavable 
bonds.  The nature of these bonds dictates the degradation behavior, as does the trigger 
that initiates degradation.  Generally these triggers fall into three different categories:  (1) 
Environmental triggers, including water, temperature and pH; (2) internal triggers which 
include stimuli that can be encountered in vivo that are controlled by surrounding cells 
such as enzymes and the oxidants and reductants that they can produce; and (3) external 
triggers that are stimuli that can be administered from outside of the system.  Since the 
first two types of triggers are not controllable, degradable systems predicated on them 
have to be pre-programmed to the desired degradation profile, and it cannot be changed 
once the material is introduced into a system.  By focusing on external triggering of 
degradation, the rates and initiation of degradation can be controlled exogenously. 
1.4.3 Degradation Control 
In an attempt to better control how biodegradable polymers degrade, many 
different types of materials have been investigated.  Poly(anhydrides) are one example of 
such a material.  When these materials were first synthesized, they were deemed to be too 
hydrolytically unstable for use in industrial applications.
40
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 When poly(anhydrides) were later investigated for biomedical applications, it 
was found that because of the hydrophobic nature of the polymer backbone, degradation 
of these materials was limited to the exterior of the polymer.
41
  Thus, hydrolysis was 
limited enough to make the material useful and improve drug delivery kinetics.  Because 
surface-eroding polymers do not release molecules by diffusion from a matrix, they are 
able to achieve almost zero-order drug release kinetics. 
Materials such as poly(acetals) have been synthesized in a different approach to 
controlling polymer degradation.  These materials are hydrolytically stable in neutral 
media, such as in the bloodstream, but are unstable in lower pH environments.
42
   When a 
polymer is internalized by a cell, it is often merged into a lysosome; the interior of a 
lysosome has a pH from around 4.7 to 5.5.
43
   This allows for a drug incorporated into 
this kind of material to be targeted to the cell’s interior. 
1.4.4 Exogenous Control of Degradation 
Once most current biodegradable polymers are put into a biological system, they 
will begin to degrade at a rate that cannot be controlled.  Once synthesized, the material’s 
degradation rate is not easily manipulated.    Researchers have developed polymer 
systems that contain degradation mechanisms that can be controlled exogenously, 
allowing degradation to be triggered.  A degradation mechanism performs well in vivo, is 
bio-orthogonal, and biocompatible could be of great utility in the field of biomaterials 
based medicine.  It could be included in polymer systems that are biologically stable and 
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in biodegradable systems.  In a hydrolytically stable polymer, most degradation would be 
via the controlled mechanism.  This would allow a physician to control the degradation of 
the material used for a tissue scaffold based on a specific patient’s recovery, keeping the 
material from degrading too quickly or slowly.  This would also be beneficial for 
targeted, low-solubility drugs that need to be used repeatedly, but sporadically.  Only 
releasing the drug when it is needed would slow the development of resistance to a 
drug
44
.  There are also uses of such a group in materials that comprise bone and tooth 
cements that may need to be removed after a period of time. 
1.4.4.1 Photodegradation of Polymers 
One approach to controlling degradation of polymer systems exogenously is 
including photo-degradable units in the polymer.  An example of this in biotechnology is 
the nitrobenzyl ester group that has been used in the synthesis of hydrogel system, most 
notably by Anseth (figure 1-9).
3-5
  The resulting hydrogel materials can have their 
properties tuned by irradiating with light to degrade crosslinks, and increase mesh size.  
Using two photon methods, gels have even been etched in 3 dimensions to make features 
within the gels.  This was done to create channels in 3D culture media for mesochymal 
cells. 
This approach shows a significant amount of utility, but is likely limited to use for 
in vitro applications, as light penetration into living tissue is minimal, and UV irradiation 
can harm living cells. 
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Figure 1-9.  An example of a light-degradable network solid.
3-5
   
1.4.4.2 Enzymatic Degradation of Polymers 
Enzymes may cleave biomaterials that have structures similar to natural materials 
such as polypeptides.  Material degradation can be controlled to an extent by considering 
enzymatic interactions.  Approaches to controlling polymer degradation based on 
enzymatic interactions include incorporating cleavable peptide sequences
45
 or urethanes
46
 
while other approaches include incorporating enzymes into polymeric materials to control 
the rate of degradation.
47
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Many different types of bonds can be cleaved by enzymes, and each requires a 
specific enzyme to do so. The use of enzymes is different than other chemical catalysts in 
 
Figure 1-10.  An example of enzymatic degradation. 
that enzyme-substrate specificity makes enzyme degradation more specific.  This is 
because the degradative capability is restricted to when a sequence of amino acids is 
recognized by the enzyme, and the longer the recognized sequence, the greater the 
specificity of the enzyme.
48
  There have been hydrogels synthesized that have an amino 
19 
 
acid sequence that is susceptible to cleavage by metalloproteinases (figure 1-10).
49
  This 
was used to template the growth of vasculature in an injured rat leg, resulting in the gel 
degradation being modulated by the release of metalloproteinase from the surrounding 
epithelial cell.
50
  Enzymes have been used to attempt control degradation exogenously, 
but the cells around the hydrogels will still affect the rate of degradation.
5
  Because of 
this, enzymatic treatment is difficult to do in a manner that is considered bioorthogonal.
51-
53
 
1.4.4.3 Chemical Degradation of Polymers 
Another approach to controlling polymer degradation is by using a chemical 
trigger to initiate degradation.  This can be difficult to envision, as most chemicals that 
would degrade a polymer would also likely not be biocompatible.  There are some 
examples of using disulfide containing crosslinkers (figure 1-11) in both hydrophobic 
materials
54
 and in hydroxyethyl methacrylate
55
 and hyalauronic acid
56
 based hydrogels.  
Glutathione is a thiol that is present in the body, and is a vital intra- and extra-cellular 
antioxidant.
57
  The ability of glutathione to participate in thiol exchange reactions makes 
its presence problematic with the use of disulfide crosslinkers in vivo because it can cause 
uncontrolled degradation.  Overall, the approach has some merit.  Given that the body is 
generally considered an oxidizing environment, a reductively degradable polymer seems 
like it should be favorable.  The key is utilizing a functional group that can be reduced 
effectively without notable reduction by endogenous thiols.
58
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Figure 1-11.  Reductively degradable disulfide croslinkers. 
1.5 Functional Groups Capable of Being Reductively Degraded 
When looking for functional groups that would efficiently be degraded, it was 
decided to look in the areas of protecting groups and cleavable linkers, as both require 
efficient methods of deprotection or cleavage.  In the area of protecting group chemistry, 
we found the 2-(azidomethyl)benzoate
6
 esters and 4-azidobutyrate esters
59
 as interesting 
candidates for the incorporation into degradable polymers.   
Both incorporate azide functional groups that are strategically placed such that 
reduction of the azide to an amine leaves the amine poised to attack the ester carbonyl 
nucleophilicly, to form a lactam.
59
  Both of these protecting groups can be removed with 
reductants such as phosphines, borohydrides, catalytic hydrogenation and H2S.
6,60-62
 
1.5.1 2-(Azidomethyl)Benzoate and 4-Azidobutyrate Based Materials 
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Two interesting functional groups for protecting alcohols and amines are the azidomethyl 
benzoate and 4-azidobutyrate groups (figure 1-12).  Both of these protecting groups are 
removed by reducing the present azide to an amine, which then acts as a nucleophile to 
attack the carbonyl, resulting in the expulsion of the alcohol or amine.  Both of these 
 
Figure 1-12.  Reductive removal of azidomethyl benzoyl and 4-azidobutyrate protecting 
groups. 
groups act in a similar manner to form 5-membered lactams as a result, and this is 
kinetically favored over larger ring systems.
63
  The differentiating factor is that the 
azidomethyl benzoate group is on an aromatic ring and the 4-azidobutyrate is aliphatic. 
The azidomethyl benzoyl group appears to be more efficient in the deprotection 
step.
6,59
  This is likely because the geometry of the aromatic ring raises the effective 
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concentration of the amine relative to the ester group.  This concept has also been 
demonstrated in solid phase peptide synthesis.
64
 
Though the two approaches have opposing results, the mechanism by which they 
take place is very similar and it is likely that these two reactions have similar kinetics.  
This is helpful because the mechanism and kinetics of the Staudinger ligation have been 
thoroughly investigated
65-66
, while the kinetics of the deprotection reactions have not 
been investigated.  It has been found that the rate-limiting step is the formation of 
coupling of the two substrates to form the phosphazide intermediate
65
, as is the case of 
the Staudinger reduction reaction.  Consequently, the reaction is second order overall. 
 
Figure 1-13.  Monomers for selectively degradable polyester materials. 
They also differ in the way by which they would likely need to be incorporated in 
a polymer(figure 1-13).  The azidomethyl benzoyl group would amenable to adding the 
azidomethyl and carboxylic acid derivative functionalities to the aromatic ring to produce 
terephthalate derivatives.  With the 4-azidobutyrate group, it would more difficult to 
symmetrize the molecule and make it homobifunctional.  The approach that seems more 
likely to succeed would be to add a hydroxyl group to the 2 position, and dimerize the 
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compound to a lactide derivative that could polymerized through a ring opening 
approach. 
 
Figure 1-14.  Fumarate based degradable monomer, with terephthalate monomer for 
comparison. 
There also exists the opportunity to synthesize an analogous compound that 
utilizes the favorable, rate increasing geometry of the azidomethyl benzoyl group in a 2-
azidomethyl fumarate system (figure 1-14).  This would allow an efficiently degradable 
group without having to rely on the aromatic core structure.  The key feature that is 
needed for this degradation mechanism is an azidomethyl group being cis to the ester.  
Alternative structures afford us flexibility in the case that a compound appears to be 
cytotoxic enough to be prohibitive, or that a synthetic route cannot be utilized. 
1.5.2 Alpha-azidoethers 
Another functional group that has shown great promise in the area of cleavable linkers is 
the alpha-azidoether group.
58
  Like the last groups presented, this group degrades through 
a mechanism that is initiated by the reduction of an azide group to an amine (figure 1-15).  
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The path of an alpha-azidoether is different in that rather than that amine acting as a 
nucleophile, the resulting alpha-aminoether spontaneously forms an imine, releasing a 
free alcohol, and fragmenting the compound.  This functional group has been used in 
DNA applications.
58
  The Kool group has engineered a fluorescence probe for detecting 
single strands of DNA.
58,67
  They engineered complementary DNA fragments with a 
phosphine on one fragment and a fluorophore, and a quencher linked via an alpha-
azidoether group.  These were arranged such that when the target DNA was present, the 
phosphine would be in close proximity to the alpha-azidoether, causing degradation, and 
release of the quencher molecule.  Overall, this meant that when fluorescence was 
observed, the target DNA was present.  Given the high extinction coefficient of 
fluorescent materials, the DNA concentrations can be monitored at very 
 
Figure 1-15. α-azidoether degradation scheme.low concentration, which 
minimizes incidental reaction of the alpha-azidoethers and phosphines in solution.  The 
Kool group demonstrated this in cellular media, and found no adventitious reduction of 
alpha-azidoethers by present thiols, demonstrating that the group is bioorthogonal.
58
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1.5.3 The Staudinger Reduction of an Azide 
The Staudinger reduction reaction (figure 1-16) is the reduction of an azide to an amine 
by treatment with a phosphine or phosphite via an iminophosphorane intermediate.
68-69
  
This intermediate hydrolyzes to give a phosphine oxide.  The azide functionality is well- 
 
Figure 1-16.  Staudinger reduction reaction mechanism. 
suited to biological environments because it is hydrolytically stable, and there is a low 
occurrence of phosphines and similar reducing agents in biological systems.
58
 
1.5.4 Kinetic Considerations 
The azidomethyl benzoyl based approach is similar to Staudinger ligation.
70
  In 
the Staudinger ligation, the phosphine reducing agent is connected to the ester and the 
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intention is to conjugate an azide by reducing and forming an amide bond.  Though the 
 
Figure 1-17.  The Staudinger ligation reaction scheme. 
two approaches have opposing results, the mechanism by which they take place is very 
similar and it is likely that these two reactions have similar kinetics (figure 1-17).  This is 
helpful because the mechanism and kinetics of the Staudinger ligation have been 
thoroughly investigated
65-66
, while the kinetics of the deprotection reactions have not.  It 
has been found that the rate-limiting step is the formation of coupling of the two 
substrates to form the phosphazide intermediate
65
, as is the case of the Staudinger 
reduction reaction.  Consequently, the reaction is second order overall.  
 The kinetics of the reduction of α-azidoethers, and their degradation have been 
studied, and it has been found that the reaction is second order, indicating that 
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phosphazide formation is the rate limiting step in those reactions as well.
71
  Since this is 
the case, even though these pathways are quite different in how they bring about 
degradation, the rate constants are expected to be similar, when all other variables are the 
same. 
1.6 Description of Chapters 
 To adequately discuss each topic in the correct context, the materials that have 
been synthesized have been separated into different categories based on how the resultant 
amine acts after the azide is reduced.  The amine either will act as a nucleophile, as is the 
case in the terephthalate and fumarate based materials, or it will rearrange to cause 
fragmentation of the compound, as happens in the case of α-azidoethers.  The first group 
was broken down further to separate most of the small molecule synthesis from the 
macromolecular materials synthesis.  
Chapter 2 details the synthesis of the dimethyl esters of both the terephthalate and 
fumarate molecules, as we decided that these would be key synthetic intermediates from 
which a variety of materials could all be made from. 
Chapter 3 describes how the intermediates described in chapter 2 were made into 
materials, and details how those materials, and their degradation, were evaluated. 
Chapter 4 is a description of both our approach of synthesizing α-azidoether 
molecules, and the many kinds of strategies that were employed to attempt to make 
degradable materials from them. 
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Chapter 2.  Terephthalate and Fumarate Materials 
Precursors 
2.1 Introduction 
The AZMB protecting group was developed as a protecting group for alcohols or 
amines, and presented as a tool for glycoside
59
 and nucleotide
6
 synthesis in 2001.  It was 
our hope to develop a terephthalate molecule that could be included into polymeric 
materials and exhibit degradation in the same fashion as the protecting group.  There are 
many examples of terephthalate polymers being used in materials, both in general and 
biomedical applications. 
Copolymers of poly(butylene terephthalate) (PBT) and PEG have been 
investigated for their suitability in applications such as drug delivery, bone replacements 
and skin substitutes.
72-74
  This block copoly(ether ester) system exhibits good 
biodegradability and biocompatibility properties while remaining relatively inexpensive.  
Novel properties are conferred by the flexible hydrophilic characteristics of the PEG 
combined with the semi-crystalline characteristics of the aromatic ester domain.  In vitro 
studies show that dermal fibroblasts
75
, epidermal keratinocytes
75
, chondrocytes
76
, and 
skeletal muscle cells
76
 proliferate on and adhere well to these materials.  Furthermore, 
subcutaneous implantation into rats gives no observable adverse tissue reactions.
77-78
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This chapter details how we have devised a synthetic protocols to access what we 
consider key small molecule intermediates for developing degradable materials based on 
2,5- (bis-azidomethyl)terephthalates, and possible intermediates for materials based on 2-
azidomethyl-fumarates. 
2.2 Results and Discussion 
2.2.1 Terephthalates 
To develop a terephthalate analog of this protecting group, we reviewed the protecting 
group synthesis.  The protecting group was synthesized by Wada et al. using either a 2-
methyl benzoic acid, or the corresponding methyl ester
6
 as a starting point (figure 2-1).  
Figure 2-1.  Scheme of literature synthesis of AZMB protecting group.
6
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This was then treated with NBS and a small amount of a radical initiator to cause radical 
bromination.
6,59
  The acid would first need to be converted to the ester to avoid 
decarboxylation in radical conditions.  The bromomethyl group is then converted to an 
azidomethyl group via treatment with azide ion under SN2 conditions.  To protect the 
functional group of interest, the methyl ester is saponified using LiOH in a THF/H2O 
mixture,
59
 then chlorinated using oxalyl chloride
6
 or thionyl chloride.
59
 
 Using these previous syntheses, we identified dimethyl 2,5-(bis-azidomethyl)-
terephthalate as a good synthetic target from which to make materials (figure 2-2).  Since 
the analogous 2,5-dimethyl-terephthalic acid is not commercially available at a 
Figure 2-2. Retrosynthetic analysis for dimethyl 2,5-bis(azidomethyl)-terephthalate. 
reasonable cost, we had to design a synthesis to produce our target molecule.  We 
reasoned that we would be able to use protocols analogous to the previously discussed 
literature protocols to make the target if we were able to start from 2,5-dimethyl 
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terephthalic acid.  We determined that 2,5-dimethyl terephthalic acid could be accessed 
from hydrolyzing  2,5-dicyano-p-xylene.  The 2,5-dicyano-p-xylene could be synthesized 
by treating 2,5-dibromo-p-xylene with Cu(I)CN.  2,5-Dibromo-p-xylene is commercially 
available, though we later found that we could synthesize it efficiently by treating p-
xylenes with elemental bromine with a catalytic amount of iodine. 
The starting material for this synthesis is p-xylene, which is a fairly common and readily 
available solvent (figure 2-3).  The conversion to 2,5-dibromo-p-xylene includes 
dissolving a couple crystals of iodine into cooled, neat p-xylene, and then slowly adding 
bromine to 
 
Figure 2-3.  Intermediate Synthesis Scheme.  a. Br2, cat I2.  b. Cu(I)CN, DMF.  c. KOH, 
diethylene glycol.  d. MeOH, cat H2SO4. e. NBS, cat AIBN, benzene.  f. NaN3, DMF. 
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get a solid product.
79
  After the remaining reactive halogen is quenched with base, the 
product is crystallized from ethanol to give a high yield (~97%) of a very pure product.  
The simplicity and efficiency of this method allows it to be easily scaled, and was 
generally scaled to the size of the bottle of bromine available. 
The next conversion is a nucleophilic substitution on an aromatic ring.  Copper (I) 
cyanide is used to introduce the cyanide ion to the halogenated aromatic compound.
80
  
The resulting 2,5-dicyano-p-xylene was sparingly soluble in acetone, allowing for the 
compound to be purified by Soxhlet extraction.  Though time consuming, this makes 
separating the desired compound from the resulting copper salts much easier.  The cyano 
groups are hydrolyzed with potassium hydroxide at high temperature over two days.  The 
resulting 2,5-dimethyl terephthalic acid was  subsequently esterified with methanol under 
acid catalysis. Benzylic bromination of the resulting methyl ester with N-
bromosuccinimide and AIBN
81
 was performed, and the desired product isolated in high 
purity after recrystallization from dichloromethane/hexanes.  Treatment with sodium 
azide in DMF facilitated SN2 displacement of the bromide functionality with an azide
82
 in 
near quantitative yields, resulting in pure dimethyl 2,5-bis(azidomethyl)terephthalate.  
We found that if the dimethyl ester was saponified, the resulting acid was not stable in 
the freezer. 
2.2.2 Fumarates 
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Having another synthetic route to materials that should degrade in a similar 
manner was of interest to us for many reasons.  An alternative material gives us another 
avenue to approach materials if there was a significant synthetic roadblock preventing us 
from making materials.  Fumarate molecules would allow for the tailoring of different 
properties as they do not have bulky aromatic rings in their structure, and the starting 
material that provides the skeleton of the molecules is inexpensive, readily available and 
renewable.  Also, since these materials will have different degradation products, their 
biocompatibility profile may be significantly different. 
The first step of this synthesis was found in the patent literature (figure 2-4).
83
  In this 
step, citric acid is converted to citraconic anhydride in one pot, rather than in multiple 
pyrolysis steps as seen in other places in the literature.
84-85
  This interesting process uses 
 
Figure 2-4. Synthesis scheme for dimethyl 2-(azidomethyl)-fumarate. 
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DMF as a catalyst in an aromatic solvent to remove two equivalents of water and one 
equivalent of carbon dioxide to form citraconic anhydride via anhydride formation, 
followed by decarboxylation and dehydration followed by isomerization.  Since multiple 
steps in the conversion are equilibria, a Dean-Stark trap is also used to push these 
equilibria in favor of the product. 
The next step involves opening the anhydride to the diester in methanol und 
Fischer esterification conditions.  This is critical in getting the desired double bond 
geometry in the next step.  After esterifaction, NBS and AIBN are used to get allylic 
bromination, and yield dimethyl 2-bromomethyl fumarate.
86
  The radical intermediate in 
this process, coupled with the close proximity of the methyl ester groups causes the 
geometry of the present double bond to isomerizes entirely from cis to trans.  This is 
important in our materials because the incorrect configuration would not give us a 
material that would degrade upon addition of a reductant.  If the sequencing of the two 
prior steps had been reversed, it would have yielded a maleate ester product rather than 
the desired fumarate ester product.
86
  The 2-bromomethyl fumarate proved to be rather 
susceptible to degradation in the presence of water.  It was found that if the next step, SN2 
displacement of the bromide with azide, was attempted in DMF, there was significant 
degradation or side reaction occurring.  We were able to solve this by switching solvents 
to the less hydrophilic acetone, and got good yields with no discernible side reaction. 
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Once the dimethyl 2-azidomethyl fumarate was synthesized, it was evaluated to 
determine if it was susceptible to reductive degradation, as we had hypothesized (figure 
2-5).  On an NMR scale, the compound was dissolved in deuterated acetonitile and 
triphenyl phosphine introduced.  Upon addition of the phosphine, the solution quickly 
began bubbling, which we believe is due to the evolution of nitrogen gas from the 
Staudinger reduction of the azide functional group.  Observation via 
1
H NMR shows 
resonances consistent with the lactam product
87
 and free methanol, indicating that the 
molecule degrades as anticipated. 
 
Figure 2-5.  Azide reduction, and consequent degradation of dimethyl 2-(azidomethyl)-
fumarate. 
It was observed that dimethyl 2-azidomethyl fumarate had a tendency to 
hydrolyze during short term storage in a freezer.  Given this tendency, and that the 
fumarate materials were not our primary target, fumarate materials were not pursued 
beyond this point. 
2.3 Safe Handling of Azide Containing Compounds 
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Safety is always an important consideration when working with both organic and 
inorganic azides.  Azides, like any compound that can degrade by expelling N2, should 
always be treated with care.  With organic azides, the inherent danger is always relative 
to the number of azides goups and the size of the molecule, though there is some 
disagreement as to what relative size of an organic azide is considered “safe.”  One of the 
rules regarding safety is that the ratio of carbon and oxygen atoms in the molecule should 
be greater than three times the number of nitrogen atoms, or (C+O)/N>3.
88
  It has been 
suggested that molecules in which this ratio is 3 or less are hazardous and prone to 
violent decomposition.  Another view that is different, though similar, is that there needs 
to be 6 carbon atoms, or other atoms of similar size, for each energetic group in the 
molecule to provide adequate enough dilution to render a molecule safe.
89
  Additionally, 
it is also advised that molecules containing energetic functional groups not be distilled in 
the research laboratory.
89
 
Hydrazoic acid, and its salts, are violently explosive, whereas dilute solutions can 
be fairly stable.  Hydrazoic acid, in addition to being thermally unstable, is quite toxic 
and shows toxicity of roughly the same order as cyanide.
89
 
These rules seem to be consistent with what we have observed in the laboratory.  In one 
instance, we had a sample degrade explosively while synthesizing 2,5-bis-(azidomethyl) 
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terephthaloyl chloride from 2,5-bis-(azidomethyl) terephthalic acid.  The carboxylic acid 
 
Figure 2-6.  Chlorination reaction and the relevant carbon and oxygen to nitrogen ratios. 
was treated with thionyl chloride at reflux, then after incubation, the excess thionyl 
chloride was vacuum distilled off gently.  Once most of the thionyl chloride had distilled 
off, about 1 g of 2,5-bis(azidomethyl)-terethphaloyl chloride exploded under vacuum.  
The vapor temperature was approximately 60 °C at the time. 
The product of the chlorination, 2,5-bis-(azidomethyl) terephthaloyl chloride, has a 
(C+O)/N number of two, which is significantly below the threshold level of 3 (figure 2-
6).  In retrospect, this was not a safe molecule make, and we are grateful that nobody was 
injured in this instance. 
2.4 Conclusion 
We have designed and performed efficient syntheses of dimethyl ester precursors 
for terephthalate and fumarate based materials.  The desired functionality is evident 
through easily identifiable features in the IR spectra of each and both degrade upon 
addition of a phosphine reducing agent. 
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2.5 Experimental Methods 
2.5.1 Materials 
Poly(ethylene) glycol reagents were purchased from LaysanBio, Inc (Arab, AL) 
unless otherwise noted. Water was purified with a Milli-Q water system (18 MΩ, 
Βillerica, MA).  All other materials were purchased from Sigma-Aldrich and used as 
received unless otherwise stated (St. Louis, MO). 
2.5.2 Terephthalate precursor synthesis 
2.5.2.1 Synthesis of 2,5-dibromo-p-xylene (30) 
 
To a stirred solution of iodine (0.35 g, 1.38 mmol) in neat p-xylene (165 mL, 1.34 
mol) that wass cooled to near 0 °C in an ice-water bath was added bromine (450 g, 2.82 
mol) dropwise over the course of three hours in the absence of light.  The reaction 
mixture was allowed to warm to room temperature and was stirred overnight under a 
nitrogen atmosphere.  To the reaction mixture was then added 20% aqueous KOH (500 
mL), and the reaction stirred until all yellow color was removed.  If the yellow color 
persists, the aqueous layer can be decanted, and another volume of 20% KOH solution 
added.  The aqueous layer is decanted, and the remaining solid washed with water (4 x 
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200 mL). Recrystallization from absolute ethanol gives product as a white crystalline 
solid (353.5 g, 97%) 
1
H NMR (CDCl3): δ 7.39 (s, 2H), 2.33 (s, 6H). 
2.5.2.2 2,5-dicyano-p-xylene (29) 
 
To a 250 mL round-bottomed flask equipped with a reflux condenser were added 
2,5-dibromo-p-xylene (8.42g, 32 mmol), copper(I) cyanide (8.99g, 100 mmol) and DMF 
(200 mL).  The reaction mixture was stirred magnetically and heated to reflux for two 
days.  After cooling to room temperature, the reaction mixture was poured into 4M 
aqueous ammonium hydroxide solution (500mL).  This gave a white precipitate in a 
bright blue solution.  The solid was vacuum filtered from the solution by use of a 
Büchner funnel.  The solid was rinsed on the funnel with the 4M ammonium hydroxide 
solution (300 mL) followed by DI water (300 mL).  Drying on the filter yielded a white 
solid with a blue tint.  The solid was continuously hot extracted with acetone for three 
days using a Soxhlet apparatus.  After three days, the yellow acetone solution was 
collected from the Soxhlet apparatus and concentrated by rotary evaporation, giving a 
brown solid.  This solid was dissolved in chloroform and passed through a plug of silica 
gel to give 2,5-dicyano-p-xylene as white needles (2.74g, 18 mmol, 55% yield): 
1
H NMR 
(CDCl3) δ 7.56 (s, 2H, Ar-H), 2.55 (s, 6H, -CH3).
80
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2.5.2.3 2,5-dimethyl terephthalic acid (28), dimethyl ester (27) 
 
 
To a 100 mL single-necked round-bottomed flask equipped with a reflux 
condenser were added 2,5-dicyano-p-xylene (2.74g, 18 mmol), potassium hydroxide 
(3.34g, 60 mmol) and diethylene glycol (50 mL).  The reaction mixture was stirred 
magnetically and heated to reflux overnight (16h).  The reaction mixture was diluted with 
water (500 mL) and acidified to pH 1 with 10% HCl.  A brown solid was filtered off 
using a Büchner funnel.  The solid was dried overnight in a desiccator and was then 
dissolved in 10% aqueous NaOH and decolorized with activated carbon.  The resulting 
solution was acidified with 10% HCl to yield a white solid which was filtered off and 
dried in a desiccator.  To a 250 mL single-necked round-bottomed flask equipped with a 
reflux condenser were added the white solid, MeSO3H (10 mL, 154 mmol), and MeOH 
(100 mL).  The reaction mixture was heated to reflux and magnetically stirred for 10h.  
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After cooling to room temperature, the reaction mixture was poured into a mixture of 
EtOAc (200 mL) and 1M phosphate buffer (pH = 7, 400 mL) and brought to a pH of 7 by 
addition of a saturated aqueous sodium bicarbonate solution.  The organic layer was 
separated and the aqueous layer washed with EtOAc (200 mL).  The organic portions 
were combined, dried with sodium sulfate and concentrated by rotary evaporation, 
yielding an orange solid.  The solid was dissolved in diethyl ether and passed through a 
plug of silica gel.  The solvent was removed by rotary evaporation, and the resulting solid 
was washed with hexanes to yield white crystals (2.06g, 9 mmol, 50% yield): 
1
H NMR 
(CDCl3) δ 7.76 (s, 2H, Ar-H), 3.90 (s, 6H, -OCH3), 2.55 (s, 6H, -CH3).
80
 
2.5.2.4 Dimethyl 2,5-bis(bromomethyl)terephthalate (26) 
 
To a 250 mL single-necked round-bottomed flask equipped with a reflux 
condenser were added dimethyl 2,5-dimethylterephthalate (2.06g, 9mmol), N-
bromosuccinimide (3.38g, 19 mmol), azobisisobutyronitrile (0.16g, 1mmol) and benzene 
(100mL).  The reaction mixture was stirred magnetically and heated to reflux for 3h.  It 
was then allowed to cool to room temperature and washed with saturated aqueous sodium 
bicarbonate solution and dried with sodium sulfate.  The solvent was removed by rotary 
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evaporation and the product recrystallized with dichloromethane/pentanes to yield pure 
dimethyl 2,5-bis(bromomethyl)terephthalate as colorless needles (3.04 g, 8 mmol, 89% 
yield): 
1
H NMR (CDCl3) δ 8.06 (s, 2H, Ar-H), 4.94 (s, 4H, -CH2Br), 2.55 (s, 6H, -
OCH3).
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2.5.2.5 Dimethyl 2,5-bis(azidomethyl)terephthalate (25) 
 
To a 125 mL Erlenmeyer flask were added 2,5-bis(bromomethyl) terephthalate 
(5.45 g, 14 mmol), NaN3 (2.03 g, 31 mmol) and DMF (35 mL).  The reaction mixture 
was stirred magnetically at room temperature overnight.  It was then diluted with DI 
water (100 mL) and extracted with EtOAc (3 x 50 mL).  The combined organic fractions 
were dried with sodium sulfate and concentrated by rotary evaporation to give a white 
solid (4.11 g, 13 mmol, 94% yield): 
1
H NMR (CDCl3) δ 8.13 (s, 2H, Ar-H),  (s, 4H, -
CH2N3),  (s, 6H, -OCH3). ; IR (cast film, NaCl) 2103, 1720, 1437 cm
-1
.  We were unable 
to obtain any useful MS data on this new compound due to the instability of the 
molecule, and the limitations of the instruments available for collecting such data. 
2.5.3 Fumarate materials 
2.5.3.1 Citraconic anhydride (33) 
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To a 500 mL round bottom flask was added 180 mL of xylenes, 20 mL of DMF, 
60.05 g (286 mmol) of citric acid monohydrate and a magnetic stir bar.  The flask was 
fitted with a Dean-Stark trap filled with xylenes, to which was fitted a condenser and 
CaCl2 filled drying tube.  The contents of the flask were stirred and heated to reflux for I 
hour, at which time the reaction mixture had taken on a red-orange color.  The contents of 
the flask were cooled to room temperature, then vacuum distilled with product being 
collected from 65 to 67 °C at 5 mbar as a clear and colorless oil (13.15 mL, 16.40 g, 51% 
yield): 
1
H NMR (CDCl3) δ 6.65 (q, 1H, =CH-), 2.20 (d, 3H, -CH3).
83
 
2.5.3.2 Dimethyl 2-methyl-maleate (34) 
 
To a 200 mL round bottomed flask was added 10.60 g of citraconic anhydride, 80 
mL of methanol, and 4 mL of concentrated sulfuric acid.  The flask was fitted with a 
reflux condenser, and the contents of the flask stirred and heated to reflux overnight.  The 
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contents of the flask were cooled to room temperature, and concentrated by rotary 
evaporation to about 25 mL total volume.  The contents were dissolved into 200 mL of 
ethyl acetate and transferred to a separatory funnel, and washed twice with saturated 
aqueous sodium bicarbonate (100 mL), twice with water (100 mL), and then brine (100 
mL).  The solution was dried over anhydrous sodium sulfate, and the solvent removed by 
rotary evaporation to yield the product as a yellow oil (12.845 g, % yield): 
1
H NMR 
(CDCl3) δ 5.75 (q, 1H, =CH-), 3.69 (s, 3H, -OCH3), 3.59 (s, 3H, -OCH3), 1.94 (d, 3H, -
CH3).
86
 
2.5.3.3 Dimethyl 2-bromomethyl-maleate (35) 
 
To a 200 mL round bottomed flask was added 4.74 g of dimethyl 2-methyl-
maleate, 100 mL of benzene, 8.01 g of NBS and 256 mg of AIBN.  The contents were 
stirred vigorously and heated to reflux for 12 hours, then allowed to stir at room 
temperature overnight.  The reaction mixture was poured into a 500 mL separatory funnel 
and washed thrice with 200 mL portions of saturated aqueous sodium bicarbonate 
solution.  The reaction mixture was then washed with 150 mL of brine, then dried over 
anhydrous sodium sulfate.  The drying agent was filtered off, and then the solvent 
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removed by rotary evaporation to yield 4.74 g of dimethyl 2-bromomethyl-fumarate as an 
orange oil: 
1
H NMR (CDCl3) δ 6.82 (s, 1H, =CH-), 4.71 (s, 2H, -CH2Br), 3.86 (s, 3H, -
OCH3), 3.81 (s, 3H, -OCH3).
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2.5.3.4 Dimethyl 2-azidomethyl-maleate (36) 
 
To a 200 mL round bottomed flask was added 5.19 g of dimethyl 2-bromomethyl-
fumarate, 100 mL of acetone, and 1.72 g of sodium azide.  This was stirred at room 
temperature over night.  The reaction mixture was then diluted with 100 mL each of ethyl 
acetate, and water in a separatory funnel, and the layers separated.  The organic layer was  
washed twice with 100 mL portions of water, then 50 mL of brine.  The solution was then 
dried over anhydrous sodium sulfate, then the  solvent was removed by rotary 
evaporation to yield 4.00 g of dimethyl 2-azidomethyl-maleate as an orange oil:
 1
H NMR 
(CDCl3) δ 6.98 (s, 1H, =CH-), 4.51 (s, 2H, -CH2N3), 3.87 (s, 3H, -OCH3), 3.81 (s, 3H, -
OCH3); IR (neat, NaCl) 2106, 1725, 1437 cm
-1
.  We were unable to obtain any useful MS 
data on this new compound due to the instability of the molecule, and the limitations of 
the instruments available for collecting such data.  
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Chapter 3. Terephthalate Based Materials 
3.1 Introduction 
Poly(ether esters) that incorporate poly(ethylene glycol) (PEG) units are garnering 
the attention of the biomedical field.
73
  Copolymers of poly(butylene terephthalate) (PBT) 
and PEG have been investigated for their suitability in applications such as drug delivery, 
bone replacements and skin substitutes.
72-74
  This block copoly(ether ester) system 
exhibits good biodegradability and biocompatibility properties while remaining relatively 
inexpensive.  Novel properties are conferred by the flexible hydrophilic characteristics of 
the PEG combined with the semi-crystalline characteristics of the aromatic ester domain.  
In vitro studies show that dermal fibroblasts
75
, epidermal keratinocytes
75
, chondrocytes
76
, 
and skeletal muscle cells
76
 proliferate on and adhere well to these materials.  
Furthermore, subcutaneous implantation into rats gives no observable adverse tissue 
reactions.
77-78
 Other terephthalate materials include composites of poly(ethylene 
terephthalate) and inorganic components such as hydroxyapatite,
90
 or silicates.
91
  
Poly(ethylene terephthalate) has good mechanical properties and is well-suited to be used 
as a matrix in such applications.
90
 
 Both of the mentioned applications are those that use terephthalate units in the 
main chain of a polymer.  The degradable unit that we have developed is suitable for use 
as a homo-bifunctional degradable crosslinker of materials as well.  Cross linked 
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materials are used in a variety of biomaterials, most notably in hydrogels, and adhesive 
resins.   
Dimethacrylate compounds are common crosslinking reagents used in dental 
adhesives and composites (figure 3-1).  These compounds include triethylene glycol 
dimethacrylate (TEGDMA)(1), bisphenol A-glycidal methacrylate (BIS-GMA) (2) and 
urethane dimethacrylate (UDMA) (3).
7
   
 
Figure 3-1.  Common crosslinking agents in dental composites: a. triethylene glycol 
dimethacrylate; b. bisphenol A-glycidal dimethacrylate; c. urethane dimethacrylate.
7
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These dimethacrylate compounds are often copolymerized with methacrylate ester 
monomers such as hydroxyethyl methacrylate (HEMA).  HEMA is an important 
component of dental adhesive composites because it is hydrophilic enough to infiltrate 
and bond to wet dentin.
29
  These adhesives are used in applications such as bonding 
braces to teeth.  The monomers and a photo-initiator are formulated into a paste, put into 
position and irradiated with light to polymerize the material in place.  When removing 
braces from a patient, it is common for some polymer to remain adhered to teeth.  This 
 
Figure 3-2.  Dimethacrylate based on modified terephthalate ester.  
residual polymer is typically removed by mechanically grinding it off of the teeth.  For 
patients with sensitive teeth, this process can be excruciatingly painful.  To avoid this, the 
crosslinking agents could be replaced with a hydroxyethyl methacrylate ester of 2,5-
bis(azidomethyl)terephthalate (figure 3-2).   
Incorporation of this compound into dental adhesives would allow the crosslinks of the 
network solid adhesive to be degraded by treatment with a phosphine or phosphite (figure 
3-3).  This could conceivably be delivered as a paste containing the reagent that is 
brushed onto teeth, in a mouth tray with a paste or gel, or as a plastic strip similar to those 
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commercially available for whitening teeth. This crosslinking agent can be synthesized 
by treatment of 2,5-bis(azidomethyl) terephthaloyl chloride with two equivalents of 
 
Figure 3-3.  Degradation scheme of a network solid. 
HEMA.  One possible advantage of this system is that the resulting polymer chains 
would be poly(HEMA) homopolymer, which is known to be biocompatible and nontoxic. 
Similar synthetic strategies could be employed to make PEG hydrogels with 
degradable crosslinks (figure 3-3).  Treatment of 2,5-bis(azidomethyl) terephthaloyl 
chloride with two equivalents PEG monomethacrylate macromers would afford suitable 
crosslinking agents.  This compound could be polymerized directly or with varying 
amounts of methoxy-PEG methacrylates to controls the degree of crosslinking in the 
hydrogel materials.  Such materials have been shown to be useful in applications such as 
tissue engineering scaffolds and drug delivery vehicles.
4
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3.2 Results and Discussion 
 The materials that were targeted first were materials that include a degradable unit 
in the crosslinks of the material.  With the abundance of methacrylate/acrylate based 
biomaterials, we decided to attempt a degradable dimethacrylate crosslinker first. The 
first step was to saponify the dimethyl ester to the terephthalic acid.  This was first done 
by treating the dimethyl ester with lithium hydroxide in 10:1 tetrahydrofuran:water at 
 
Figure 3-4.  Saponification of the dimethyl ester to the carboxylic acid. 
room temperature (figure 3-4).
59
  This was attempted in order to keep reaction 
temperature low to protect the thermally unstable azide.  We were able to later determine 
that the same results could be achieved by refluxing the dimethyl ester in 5% aqueous 
sodium hydroxide for around 30 minutes.  This process is much quicker and gives a 
similar yield without any apparent degradation of the azide functionality.  The 
dicarboxylic acid was then chlorinated in either thionyl chloride or oxalyl chloride to 
yield the diacid chloride in near quantitative yield.  As previously mentioned, we did 
experience an explosive decomposition during this step once while distilling off excess 
thionyl chloride, so the use of oxalyl chloride is preferred for this conversion, as the 
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excess can easily be distilled off under vacuum at room temperature.  Treatment of the 
the diacid chloride with anhydrous ethylene glycol and pyridine in tetrahydrofuran gave a 
diester of ethylene glycol, which was then capped with methacrylate functionality by 
  
Figure 3-5.  Conversion of dimethyl ester intermediate into a dimethacrylate crosslinker 
via an acid chloride. 
treatment with methacryloyl chloride under the same conditions (figure 3-5).  Given the 
safety concerns of this synthetic pathway, most notably with the observed instability of 
the diacid chloride, another synthetic pathway was developed as well.  We were able to 
obviate the need to go through the diacid chloride intermediate by using di-cyclohexyl-
cabodiimide coupling chemistries to make a terephthalate ester directly from the diacid 
and hydroxyethyl methacrylate (figure 3-6).  This allows for a reduction in the number of 
steps, and the yield is comparable to the overall yield of the other pathway.   
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Figure 3-6.  Conversion of the carboxylic acid into a dimethacrylate crosslinker with 
DCC. 
 With the desired dimethacrylate crosslinker in hand, we attempted to use it to 
make a crosslinked material with varying ratios of hydroxyethyl methacrylate.  Solutions 
of monomers and crosslinker were initiated using benzoyl peroxide and AIBN, but 
whenever the azide modified group was present, no polymerization was observed.  
Samples of the same supply of hydroxyethyl methacrylate were initiated, and 
polymerized as expected.  This was quite surprising and unexpected, and for quite awhile 
we were not able to explain these results, and moved on to other materials that did not 
require radical polymerization.  This is also consistent with other experiments that we 
 
Figure 3-7.  Scheme for synthesizing azide-bearing styrene derivatives. 
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have conducted using similar molecules.  In an unrelated project, we have synthesized 4-
vinyl benzyl azide, from the corresponding chloride, and attempted to polymerize it 
radically to obtain hydrophobic polymers that could be treated with a reductant to make 
them hydrophilic (figure 3-7).  When attempting a radical polymerization of this 
molecule, we observed no polymerization as well.  At first, it was hypothesized that the 
C-H bond on the benzyl carbon would be weak due to stabilization of the resulting 
radical by the aromatic ring and the alpha heteroatom.  A search of the literature, 
however, did not support this.  Upon further review, we were able to find instances in the 
literature of researchers observing the reaction of azide groups with vinyl monomers.
92
  It 
was observed by Perrier et al that the loss of azide was observed in previous publications, 
but never explained.
93
  They were able to determine that azide functionalized reagents 
Figure 3-8.  An alkyl azide undergoing a cycloaddition with the vinyl group of a 
monomer. 
were in fact reacting with N-isopropylacrylamide in a 1,3 dipolar cycloaddition, similar to 
those observed by Huisgen
94
 and L’Abbe95 in their pioneering work (figure 3-8).  Perrier 
et al were able to isolate and confirm the resulting triazolines, and the aziridine that 
results from their decomposition.  It is not clear if this is the only reason that 
polymerization with these materials was problematic, but it was enough to motivate us to 
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look for different functional groups that would allow the facile synthesis of materials 
without such challenges. 
 When searching the literature to find a suitable alternative to dimethacrylate based 
cross linkers, we found many examples of using epoxy-amine chemistry to fabricate 
hydrogel materials.
96-98
  This chemistry has many benefits over chemistries like radically 
polymerization in that it does not require any additional initiators or incipients in the 
material that can cause biocompatibility issues.  With this in mind, we focused on making 
terephthalate esters that had epoxide functionality. 
 
 
Figure 3-9.  Scheme for adding functionality using epichlorohydrin. 
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To provide the desired functionality, we targeted the diglycidyl ester of the 
terephthate.  To access this ester, we saponified the dimethyl ester as before, formed the 
disodium carboxylate salt by treatment with sodium hydride, then incubated the salt in 
neat epichlorohydrin (figure 3-9).  This yields the diglycidyl terephthalate as an oil. The 
diglycidyl ester was found to be susceptible to hydrolysis, even when stored under N2, 
and in a freezer.  A relatively easy way to preserve this compound during storage is to not 
wash the mineral oil from the sodium hydride, as it forms a hydrophobic layer over the 
isolated product when stored in a small vial.  This oil can be removed by washing with 
hexanes prior to use. 
             
Figure 3-10.  Using diglycidyl esters and amine terminated PEG to form hydrogels. 
To produce hydrogels from the diglycidyl terephthalate compound, two 
equivalents of the ester were combined with amine-terminated four-armed star 
poly(ethylene glycol) (Mn = 10,000 g/mol) in DMSO, and heat at 150 °C overnight under 
nitrogen (figure 3-10).  After this incubation, nitrogen was streamed over the reaction vial 
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to concentrate the reagents, and complete the reaction.  After all visible solvent is gone, 
the vial is allowed to cool, then water added to the material to swell the gel.  The vial 
often has to be broken to remove the hydrogel material (figure 3-11).  After removal 
      
Figure 3-11.  Synthesized and swollen hydrogels, both in (left), and out (right) of the vial. 
from the vial, the hydrogel was allowed to sit in DI water overnight, after which time it 
became clear and colorless, and undetectable while submerged in water.  The hydrogel 
was cut into pieces for testing.   
 The first analysis of the material that was conducted was a mass loss study, in 
which gel fragments were incubated in both a 10 mM aqueous tris(2-
carboxyethyl)phosphine hydrochloride solution, and in DI water, to serve as a control.  
The orginal masses of the gels were recorded, then every 24 hours, the gels were 
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removed, blotted twice with brown paper towels, then the mass recorded.  Since tris(2-
carboxyethyl)phosphine solutions oxidize in the presence of atmospheric oxygen, the 
solutions were replaced every 48 hours, which was done on days 3 and 5.  Shortly after 
addition of the gel to the reductant solution, bubbles were observed on the material, 
which are presumably nitrogen gas being evolved from the reduction of the azide 
 
Figure 3-12.  Mass of hydrogels over time in water and 10 mM TCEP solution.  
functional groups.  As expected of a hydrogel that has degrading crosslinks, the mass first 
increased before it decreased (figure 3-12).  This is due to a hydrogel’s ability to swell 
more as the crosslink density of the material becomes smaller, before enough of the 
material is soluble polymer that dissolves into the solution.  Qualitatively, as time 
progressed, the gel became noticeably less rigid, as expected.  Also noted was a light 
increase in the mass of the control gel, indicating that the sample was not completely 
swollen to equilibrium at the time that testing began. 
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 We were also able to evaluate the materials by time lapse photography (figure 3-
13).  To do so, hydrogel disks were fashioned by punching the hydrogel with glass 
tubing.  These disks were then incubated in a solution of Congo Red for 3 days to dye 
them red.  A disk was placed in solutions of 50 mM aqueous tris(2-
carboxyethyl)phosphine hydrochloride solution, DI water and 50 mM hydrochloric acid 
solution.  The acid solution was used as a control to verify that the 
 
Figure 3-13.  Time-lapse photographs of dyed hydrogels over time, under degradative 
(center) and control conditions (left and right). 
hydrochloric acid present in the aqueous tris(2-carboxyethyl)phosphine hydrochloride 
solution was not responsible for any observed degradation.  Since Congo Red changes 
from red to blue in pH less than 3.0, the disks in aqueous tris(2-carboxyethyl)phosphine 
8.5 h
24 h
1 min
DI Water 50 mM TCEP·HCl 50 mM HCl
cross-section
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hydrochloride solution, and the hydrochloric acid solutions were dark purple in color, 
rather than the red color of the control in DI water.  Upon addition of the hydrogel disks 
to the tris(2-carboxyethyl)phosphine hydrochloride solution, bubbles were observed 
within the first few minutes, whereas there were no bubbles observed on the two control 
samples.  As time went by there did not appear to be much change when viewed from 
above, but when looked at from the side at 8.5 hours, the hydrogel sample in the tris(2-
carboxyethyl)phosphine hydrochloride solution was demonstrably thinner.  After 24 
hours, the hydrogel had degraded completely, whereas the two control samples appeared 
completely unchanged.  The undegraded hydrogel disks were observed for more than two 
weeks, with no change in appearance being noted.  By observation, these hydrogel disks 
remained intact in water for over 6 months at room temperature, with only a slight 
leaking of the dye being observed. 
 Other attempts were made to form hydrogels in dimethyl sulfoxide, without the 
concentration step, but all of those materials failed to stay intact when soaked in DI 
water.  The heating time was increased to over a week, yet it appears that the reaction is 
not complete enough to produce hydrogels.  Extended heating without concentration 
appears only to allow the amine to auto oxidize to a greater extent.  It is thought that the 
epoxide-amine reaction is fairly slow in these conditions because of the relatively low 
concentration of the two functional groups in the material. 
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3.3 Conclusion 
In this chapter, we have shown that we were able to successfully synthesize 
materials from the dimethyl 2,5-bis(azidomethyl) terephthalate precursor, and that those 
materials show the expected degradation behavior when a reductant is added.  We were 
able to add polymerizable functionality to the 2,5-bis(azidomethyl)-terephthalate core in 
the forms of dimethacryalates and diglycidyl esters.  It is unfortunate that the radical 
polymerizable dimethacrylate crosslinker does not function as planned, due to likely side 
reactions.  We felt that this system had potential as a selectively degradable adhesive 
resin for orthodontic applications.  Though the problem was observed early on, the 
probable cause was recognized too late to expand the study of the system, and possibly 
find a solution, or at least confirm the side reaction.  The diglycidyl esters are interesting 
and have the potential to be useful as degradable adhesives, but unfortunately we were 
not able to test the performance of materials that would have required such a large 
fraction of the material to be the azide modified terephthalate due to the inability to 
access sufficient quantities of the compound. 
3.4 Experimental  
3.4.1 2,5-bis(azidomethyl)-terephthalic acid (38) 
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3.4.1.1 Method A. 
To a 125 mL Erlenmeyer flask was added dimethyl 2,5-bis(azidomethyl) 
terephthalate (0.88g, 2.89 mmol), LiOH (1.23g, 51 mmol), THF (50 mL) and DI water (5 
mL).  The flask was covered with parafilm and stirred magnetically for 60 h.  The 
reaction mixture was diluted with 100 mL of DI water and extracted with 
dichloromethane (3 x 30 mL).  The aqueous layer was acidified with 10% HCl, giving a 
white precipitate.  This solution was extracted with EtOAc (3 x 30 mL).  The combined 
organic fractions were dried with sodium sulfate and concentrated by rotary evaporation, 
giving a white solid(0.77 g, 2.77 mmol, 96% yield): 
1
H NMR (10% NaOD in D2O) δ (s, 
2H, Ar-H),  (s, 4H, -CH2N3). 
3.4.1.2 Method B 
To a 125 mL Erlenmeyer flask was added dimethyl 2,5-bis(azidomethyl) 
terephthalate (1.01 g, 3.31 mmol), and 5% aqueous sodium hydroxide solution (50 mL).  
The flask was fitted with a condenser, heated to reflux, and stirred magnetically for 2 h.  
The reaction mixture was diluted with 100 mL of DI water and extracted with 
dichloromethane (3 x 30 mL).  The aqueous layer was acidified with 10% HCl, giving a 
62 
 
white precipitate.  This solution was extracted with EtOAc (3 x 30 mL).  The combined 
organic fractions were dried with sodium sulfate and concentrated by rotary evaporation, 
giving a white solid(0.86 g, 3.12 mmol, 94% yield): 
1
H NMR (10% NaOD in D2O) δ (s, 
2H, Ar-H),  (s, 4H, -CH2N3). 
3.4.2 2,5-Bis(azidomethyl) terephthaloyl chloride (39), 2,5-bis(2-
hydroxyethyl)2,5-Bis(azidomethyl) terephthalate (42) 
 
To an oven-dried 100 mL round-bottomed, single-necked flask were added 
anhydrous THF (20 mL), 2,5-bis(azidomethyl) terephthalic acid (0.42 g, 1.38 mmol) and 
oxalyl chloride (25 g, 197 mmol).  The reaction mixture was heated to reflux and stirred 
magnetically overnight under a nitrogen atmosphere.  The reaction mixture was distilled 
under house vacuum until only ~10% liquid remained.  At this point a 12 inch needle was 
used to stream dry nitrogen over the reaction mixture until the liquid was gone, yielding 
2,5-bis(azidomethyl) terephthaloyl chloride as a yellow solid.   The solid was dissolved 
into anhydrous THF (25 mL).  To another oven-dried 100 mL round-bottomed, single-
necked flask was added anhydrous THF (10 mL), ethylene glycol (20 mL, 359 mmol) 
and pyridine (2 mL, 24.8 mmol).  This solution was stirred and the terephthaloyl chloride 
solution was added dropwise under a nitrogen atmosphere.  The reaction mixture was 
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stirred overnight.  To the reaction mixture was added 100 mL of DI water.  This was then 
poured into a separatory funnel with 100 mL of EtOAc.  The phases were separated, and 
the aqueous layer was extracted with EtOAc (3 x 50mL).  The combined organic 
fractions were washed with brine and dried with sodium sulfate.  The solution was 
concentrated by rotary evaporation, yielding a wet yellow solid.  The solid was dissolved 
in EtOAc (50 mL) and washed with water (3 x 40mL).  The organic phase was dried with 
sodium sulfate and concentrated by rotary evaporation, yielding off-white crystals (0.44 
g, 1.21 mmol, 88% yield): 
1
H NMR (CDCl3) δ 8.13 (s, 2H, Ar-H), 4.83 (s, 4H, -CH2N3), 
4.52 (m, 4H, -CH2CH2OH), 4.01 (m, 4H, -CH2CH2OH).  
3.4.3 Bis(2-(methacryloyloxy)ethyl) 2,5-bis(azidomethyl) terephthalate 
(40) 
3.4.3.1 Method A 
 
To an oven-dried 100 mL round-bottomed, single-necked flask were added 
anhydrous THF (40 mL), bis(2-hydroxyethyl)2,5-bis(azidomethyl) terephthalate (0.44 g, 
1.21 mmol) and anhydrous pyridine (0.10 mL, 1.3 mmol).  The flask was closed with a 
rubber septum, and the solution was stirred magnetically under a nitrogen atmosphere. 
Methacryloyl chloride (0.13 g, mL, 1.3 mmol) was added dropwise via a needle and 
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syringe.  After stirring magnetically overnight, the reaction mixture was poured into a 
250 mL separatory funnel.  The reaction mixture was diluted with EtOAc (50 mL), and 
then DI water (20 mL) was slowly added to quench any unreacted methacryloyl chloride.  
The phases were separated and the aqueous phase extracted with EtOAc (2 x 30 mL).  
The combined organic phases were washed with 10% aqueous sodium bicarbonate 
solution (50 mL).  The organic phase was dried with sodium sulfate and concentrated by 
rotary evaporation to give a yellow oil (0.59 g, 1.19 mmol, 98% yield):
 1
H NMR (CDCl3) 
δ 8.13 (s, 2H, Ar-H), 6.17 (s, 2H), 5.63 (s, 2H), 4.84 (s, 4H, -CH2N3), 4.55 (m, 8H, -
OCH2CH2O-) 1.97(s, 6H, -CH3). 
3.4.1.2 Method B 
 
To a 250 mL round-bottomed flask was added dry THF (125 mL), 2,5-
bis(azidomethyl)-terephthalic acid (0.97 g, 3.62 mmol), DCC (2.43 g, 10.9 mmol), 
DMAP (0.32 g, 2.6 mmol), and HEMA (1.34 mL, 1.44 g, 11.1 mmol) and the mixture 
was stirred at room temperature overnight.  This resulted in a white, opaque mixture.  The 
mixture was gravity filtered to remove the solids, and the resulting solution concentrated 
at reduced pressure in a rotary evaporator to give a white solid and a yellow oil.  The 
product mixture was place on a Büchner funnel and rinsed with a small amount or 
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chloroform.  The filtrate was collected and the solvent removed by rotary evaporation at 
reduced pressure to yield the dimethacrylate product as a yellow oil. (1.07 g, 2.14 mmol, 
59% yield):
 1
H NMR (CDCl3) δ 8.13 (s, 2H, Ar-H), 6.17 (s, 2H), 5.63 (s, 2H), 4.84 (s, 
4H, -CH2N3), 4.55 (m, 8H, -OCH2CH2O-) 1.97(s, 6H, -CH3). 
3.4.4 Diglycidyl 2,5-bis(azidomethyl) terephthalate (49) 
 
To a 150 mL Erlenmeyer flask was added 2,5-bis(azidomethyl)-terephthalic acid 
(0.80 g, 2.90 mmol), acetonitrile (15 mL) and sodium hydride (0.350 g, 60% suspension 
in mineral oil, 8.7 mmol).  This was stirred for 30 minutes at room temperature, at which 
time 50 mL of epichlorohydrin was added to the flask, and the flask heated to 100 °C for 
36 hours.  The flask was cooled to room temperature, then the contents poured into a 1 L 
separatory funnel, along with benzene (200 mL), and water (200 mL).  The layers were 
separated, and the organic layer washed with water  (3 x 200 mL).  The organic layer was 
then dried with brine (200 mL), then the solution was dried further over anhydrous 
sodium sulfate.  The solvent was removed by rotary evaporation at reduced pressure.  The 
flask was placed on a Schlenk line under high vacuum overnight to remove any residual 
epichlorohydrin.  The remaining solids were collected and purified by recrystallization 
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from dichloromethane/hexanes to yield both white crystals, and a viscous oil.  Both 
products look identical by 
1
H NMR analysis, and it is thought that a single diastereomer 
crystallized.  This yielded 0.036 g of white crystals, and 0.106 g of the oil (13% yield): 
1
H NMR (CDCl3) δ 8.16 (s, 2H, Ar-H), 4.87 (s, 4H, -CH2-N3), 4.72 (dd, 2H), 4.20 (dd, 
2H), 3.38 (dddd, 2H), 2.94 (dd, 2H), 2.75 (dd, 2H). 
3.4.5 4-Vinylbenzyl azide (44) 
 
To a 100 mL round bottomed flask was added 4-vinylbenzyl chloride (6.30 g, 
41.3 mmol), DMF (60 mL) and sodium azide (6.35 g, 98 mmol).  This was stirred 
overnight at room temperature.  The reaction mixture was diluted with ethyl acetate (200 
mL), and washed with 13% aqueous sodium chloride solution (3 x 200 mL), then dried 
over anhydrous sodium sulfate.  The solvent was removed by rotary evaporation at 
reduced pressure to yield a yellow oil (6.37 g, 40 mmol, 97% yield): ): 
1
H NMR (CDCl3) 
δ 7.35 (d, 2H), 7.20 (d, 2H), 6.65 (dd, 2H), 5.70 (dd, 2H), 5.21 (dd, 2H), 4.23 (s, 2H). 
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Chapter 4.  Alpha-Azidoether Based Materials 
4.1 Introduction 
There has been much research interest in recent years in discovering reactions that 
are bioorthogonal.  They are called this because they do not participate in the reactions 
that take place in the processes of biological systems.  This bioorthogonality is usually 
imparted by using functional groups that are not normally present in most biological 
environments.  These functional groups are generally used for ligation and cleavage.
51,53
  
Ligation is the connecting of two objects, whereas cleavage serves the opposite function.  
These are the fundamental processes for techniques such as detection, purification and 
modification of biomacromolecules.
99-100
   
 
Figure 4-1. Reductive degradation of an α-azidoether. 
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A functional group that may be amenable to cleavage under mild, in vivo 
conditions is the α-azidoether functional group (figure 4-1).  The azide functional group 
is considered bioorthogonal and is used in the popular “click” reaction, and the 
Staudinger ligation.
101-102
  In the presence of a suitable reducing agent, the azide 
functional group is reduced to an amine, which rearranges spontaneously to fragment the 
molecule, then hydrolyzes to an aldehyde and alcohol.  This functional group has been 
used DNA sequence analysis and organic synthesis, though it has not been investigated as 
a polymeric component.
58,67,103
  
 The synthesis of α-azidoethers was first reported by Birkofer et al.104  In their 
method, aldehydes were treated with trimethylsilyl azide in the presence of a zinc 
chloride catalyst to give α-trimethylsiloxy-alkyl-azides (figure 4-2).  Since this original 
  
Figure 4-2.  Reaction of an aldehyde and TMSN3 to give an α-trimethylsiloxy-alkyl-
azide. 
synthesis, many different methods have been discovered for making these types of 
compounds.  During the course of our work of synthesizing α-azidoethers, we took two 
approaches that differed from the original synthesis that were used.  The primary 
69 
 
syntheses used by our group were modified versions of the synthesis reported by Olah et 
 
Figure 4-3.  Reaction of an acetal with TMSN3 to give α-azidoether. 
al.
105
  The primary modification of the procedure was the use of zinc chloride in place of 
tin(IV) chloride.
71
  This Lewis acid is less expensive and easier to handle, and in our 
work, we were able to achieve better than the reported yields while using it.  The work in 
our group synthesizing novel α-azidoether molecules took two different approaches, 
making diols
106
, and making diamines.
71
   
 
Figure 4-4. Scheme for synthesis of an α-azido ether containing diol. 
The diol synthesis is detailed in figure 4-4.  From this molecule, dimethacrylate materials 
can be accessed by treating with methacryloyl chloride.  The alcohol groups could also be 
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treated with methane sulfonyl chloride, then ammonia to access a diamine as well.  It was 
observed with this material that any treatment with a base to make the oxide more 
nucleophilic for substitution reactions leads to acetal formation and the loss of the azide 
functionality (figure 4-5).  This is problematic because contamination of the bifunctional 
 
Figure 4-5.  Treatment of this diol α-azidoether results in elimination of an azide ion. 
reagent with a monofunctional one has the potential to cripple any polymerization 
attempt.  The alternative would be to use an acid catalyzed substitution method, but it has 
also been observed that the α-azidoether functional group is less hydrolytically stable 
under acidic conditions.
71
  One approach that was taken to avoid this was to oxidize the 
primary alcohol to a carboxylic acid.  This gives a heterobifunctional molecule with an 
alcohol at one end and a carboxylic acid at the other.  This was attached via the 
carboxylic acid to the ends of amine terminated poly(ethylene glycol), then the terminal 
hydroxyl groups were capped with methacrylate functionality, to give a dimethacrylate 
macromolecular crosslinker, as detailed in figure 4-6. 
The approach of synthesizing diamines, detailed in figure 4-7, may give a little bit better 
synthetic utility, due to end groups that are more nucleophilic at neutral pH conditions.  
This approach utilizes potassium phthalamide salts as nucleophiles to add protected 
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Figure 4-6.  Scheme of the synthesis to produce dimethacrylate macromeolecular 
crosslinkers bearing α-azidoether functional groups. 
amine functional groups to the molecule.  This results in a molecule that has little 
tendency to cyclize and expel an azide group, and can be stored as the diphthalimide at 
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room temperature, or as the diamine in the freezer.  Using this synthetic route, coworkers 
have made poly(amide), acrylamide crosslinkers, and phosphonate acrylamide adhesives.   
 
Figure 4-7.  Scheme for the synthesis of a diamine α-azidoether. 
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 In this chapter I am detailing my attempts to produce materials that degrade as a 
result of a spontaneous rearrangement after an azide is reduced to an amine.  We believe 
that there is great potential for future work with these compounds.  Not all of these 
attempts were successful, or fully evaluated due to the time constraints necessitated by 
the temporary nature of graduate school.  I have personally learned something about the 
nature of these compounds from each trial, however, and believe that detailing them here 
may serve to help other do so as well. 
4.2 Results and Discussion 
 With our relative success with synthesizing terephthalate epoxy-amine based 
hydrogels, we decided that epoxy-amine materials would be a good place to start as well 
for α-azidoether materials as well.  Our first approach was to convert a diol to a 
Figure 4-8.  Scheme for conversion of diol α-azidoether to diglycidyl ethers. 
diglycidyl ether (figure 4-8).  In an attempt to avoid, or minimize, acetal formation, a 
relatively weak base was required, and the reactions were done solvent free since the 
reactants are liquids.  Our first attempt was to dissolve the diol in neat epichlorohydrin, 
then add potassium carbonate.  While a small amount of the desired diglycidyl ether was 
observed, the majority of the product mixture was a combination of monoglycidyl ether, 
the acetal byproduct, and especially if the reaction were heated to push it to completion, 
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an acetal byproduct with a glycidyl ether.  Another approach that was taken was to 
attempt to synthesize the diglycidyl ether of the α-azidoether in two steps rather than one 
 
Figure 4-9.  Scheme of an attempt to make diglycidyl ethers of the diol α-azidoether by a 
2 step process, via the diallyl ether. 
by first converting to the diallyl ether, then epoxidizing the alkene (figure 4-9).  
Unfortunately, the attempted ether formation yielded similar results to trying to form the 
compound directly.   
 These difficulties lead to the decision to pursue a different synthesis strategy.  It 
was hypothesized that we could synthesize an α-azidoether was already end-
functionalized with allyl ethers, which could be oxidized to epoxides.  There is a reported 
synthesis of making an α-azidoether that consists of treating an aldehyde with 
trimethylsilyl azide, iron(III) chloride, and a trimethylsilyl ether to form an α-azidoether 
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(figure 4-10).
107
  To try this synthesis method, both of the reagents needed to be 
synthesized, as neither is readily available by commercial suppliers.  The allyl 
Figure 4-10.  An alternative synthesis for making α-azidoether molecules. 
trimethylsilyl ether was accessible by treatment of the allyl alcohol with trimethylsilyl 
chloride in the presence of pyridine.  The allyl glycal ether was not easily accessible.  
Glycal was only commercially available as an aqueous solution, making a Williamson 
ether synthesis difficult.  Upon reviewing the literature, we were able to find an elegant 
and simple way to access the dimethyl acetal of glycal(figure 4-11).
108
  The synthesis is a 
one pot reaction of first the epoxidation of ethyl vinyl ether by MCPBA in methanol, 
followed by the addition of sulfuric acid.  This results in oxidation of the alkene to an 
epoxide, which is then opened by the methanol and acid to the ethyl, methyl glycal mixed 
acetal.   This equilibrates in the excess methanol and acid catalyst to the dimethyl acetal 
of glycal.  This compound can be treated with base and allyl bromide to yield the desired 
dimethyl acetal of the allyl glycal ether, which can be treated with dilute aqueous acid to 
yield the desired aldehyde, and a sense of satisfaction for the researcher who found such a 
clever, but simple pathway.  Once these two compounds were in hand, the coupling 
reaction was run, and there is evidence that we were able to attain the desired product in a 
disappointing 0.5% yield.  The 
1
H NMR spectra was not fully interpretable, but we were 
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able to observe the aldehyde proton signal disappear, and the familiar triplet of the proton 
geminal to the azide group appear, which indicates that an α-azidoether was formed. 
 
Figure 4-11. Scheme for the synthesis of glycal allyl ether. 
Given the dismal yields of the synthesis, however, it was decided to make materials from 
the more efficient protocols developed by coworkers.       
We decided that the next logical step would be to use an amine that had the α-
azidoether functionality built in, rather than the epoxide, as others in the research group 
had already devised an efficient synthesis to this diamine intermediate.  This synthesis 
begins with treatment of the commercially available 2-(chloromethyl)-1,3-dioxolane with 
potassium phthalimide to yield 2-(phthalimidomethyl)-1,3-dioxolane.  This was treated 
with catalytic zinc chloride in neat trimethylsilyl azide to open the ring and upon workup 
give 2-azido-2-(2-hydroxyethoxy)ethyl phthalimide.  This is treated methanesulfonyl 
chloride to afford the corresponding mesolate from the alcohol.  The mesolate is treated 
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with potassium phthalimide to yield the diphthalimide, which can then be deprotected 
with hydrazine to give the diamine.   
The first material attempted using the synthesized diamine was done by 
combining the 2-(2-aminoethoxy)-2-azidoethanamine with diethylene glycol diglycidyl 
 
Figure 4-12.  Synthesis of diethylene glycol diglycidyl ether using a phase transfer 
catalyst. 
ether.  The diglycidyl component was synthesized by treating diethylene glycol first with 
sodium hydride, then allyl bromide in the presence of the phase transfer catalyst 
tetrabutyl ammonium bromide (figure 4-12).  The diamine and diepoxide compounds 
were mixed together without solvent, and allowed to cure at room temperature for 24 
hours (figure 4-13).  When no apparent reaction was observed, other than slight oxidation 
of the amine, another attempt was made, but the mixture was heated at progressively 
higher temperatures until a sample was heated at 120 °C for 24 hours.  Inexplicably, 
heating only seemed to increase the rate of amine oxidation.  Since this was meant only 
to be a model material, work on this material was not further pursued. 
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Figure 4-13.  Synthesis of hydrophilic materials using the diamine α-azidoether and 
diethylene glycol diglycidyl ether. 
We next moved to using a functional group that was more reactive with amines, 
isocyanates.  Polyureas and polyurethanes are used in many applications, including 
biomaterials applications.  With many diisocyanate compounds commercially available, 
this appears to be a good are in which to pursue materials.  By adding the diamine to 
diisocyanates, we could produce degradable polyureas. Treatment of the diamine with an 
excess of diisocyanate produces isocyanate capped materials that could be combined with 
diols to produce degradable polyurea-urethanes.  There was also the possibility of 
converting the amine endgroups to isocyanates directly using phosgene or a similar 
reagent such as triphosgene, or carbonyl diimidazole. 
The availability, low cost and relative safety inclined us to try making materials 
using commercially available diisocyanates.  We purchased for these experiments 
tolylene-2,4-diisocyante (TDI), and methylene diphenyl-4,4’-diisocyanate (MDI) (figure 
4-14).  TDI and MDI were favorable because they are so widely used in industry.  Initial 
materials were formed by dissolving TDI and MDI into dichloromethane, and then 
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adding an equimolar amount of the diamine to each slowly (figure 4-15).  The ensuing 
 
Figure 4-14.  Commercially available diisocyanate compounds: TDI (87) and MDI (88). 
reaction was very exothermic, and resulted in brittle polyurea foams that are not readily 
soluble in any solvent that was tried.  It is believed that this is due to the strong hydrogen 
bonding characteristic of the urea functional group.    
Figure 4-15.  Polyureas synthesized from commercially available diisocyanates and the 
diamine α-azidoether. 
Another approach taken was treatment of the diamine with an excess of TDI  to 
give a molecule with isocyanate endgroup functionality, then combining that compound 
with 1,8-octane- diol to make a polyurea-urethane (figure 4-16).  This resulted in a less 
brittle, elastomeric material that also had quite a bit of tack.  This approach seems 
favorable as the material properties could be tuned by changing the diol used in the 
synthesis. 
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Other research areas included trying to insert the degradable α-azidoether group 
into existing monomers used to make polymeric biomaterials (figure 4-18).  Looking at 
 
Figure 4-16.  Polyurea-urethane synthesized from diamine α-azidoether, TDI, and 1,8-
octane diol. 
the structure of lactide, it appeared to us to be a reasonable candidate as a 
substrate for radical bromination, from which we could make the corresponding azide.  
Treatment of lactide with NBS and catalytic AIBN gave the desired brominated lactide 
molecule (figure 4-17).  Two things that were observed were that regardless of the 
stoichiometry or NBS relative to lactide, only a small amount (<5%) of the dibromination 
product was 
 Figure 4-17.  Synthesis route for adding azide functionality to lactide. 
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observed, and that the brominated lactide was very susceptible to hydrolytic degradation.  
It was found that for the conversion to the azide a relatively hydrophobic solvent was 
required, after attempts of conversion in DMF yielded only degradation of the starting 
material.  Because of this, benzene was used for the SN2 conversion of the bromide to the 
azide, and was found to be quite suitable for the desired reaction. 
 
Figure 4-18.  Polymerization and degradation scheme of azide modified lactide. 
 With the azide modified lactide in hand, polymerization was attempted.  
Benzyl alcohol was used as an initiator and DBU and tin(II) octanoate were each used as 
catalysts.  No measurable polymerization was observed using either system.  Careful 
examination of the polymerization mechanism reveals the likely problem.  Once a ring 
has opened, the resulting propagating oxide can form a carbonyl and eliminate an azide 
anion, which is a much better leaving group than the oxide, rather than open another ring 
monomer (figure 4-19).  It is unfortunate that this was the case, and that we did not 
discover this shortcoming prior to synthesizing the compound.  It may be possible to 
apply the same methodologies to poly(lactide) and get degradable materials in that 
fashion.  Qualitatively, the azide located α to an ether, and α to an ester carbonyl seems to 
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reduce quickly.  So quickly in fact that during our first attempt to follow the reduction via 
1
H  
 
Figure 4-19.  Proposed mechanism of attempted polymerization of azide-modified  
lactide. The reaction is represented as a base catalyzed reaction, with the catalyst omitted 
for clarity. 
NMR resulted in such a quick evolution of nitrogen gas that it was not possible to keep a 
cap on the sample tube immediately after adding a reducing agent. 
4.3 Safety 
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In the course of the synthesis described in this chapter, trimethylsilyl azide is used in 
significant quantities, and during our research, we synthesized the vast majority of the 
compound that we used.  This was generally done by conducting the synthesis on a scale 
that produces roughly 200 grams of the compound per iteration.  After having 
successfully executed this synthesis without incident numerous times, an accident 
ocurred during the purification by distillation.  In the accident, I was fortunate to not have 
been more severely injured, though I will carry effects of this accident with me for the 
rest of my life.  After the accident, we submitted a safety letter to the Chemical & 
Engineering News
109
 describing the event, and it is reproduced below. 
  “We recently conducted a synthesis of azidotrimethylsilane (TMS-N3) that 
resulted in an explosion, significant damage to the reaction hood, and injuries to a student 
researcher. Although it is still not entirely clear what caused the explosion, it seems likely 
that the reaction and isolation conditions generated hydrazoic acid (HN3) that detonated 
within the reaction flask. We write to recommend extra precautions when conducting 
larger-scale syntheses of TMS-N3. 
TMS-N3 is commonly synthesized by reaction of chlorotrimethylsilane with sodium azide 
and isolated by direct distillation of the TMS-N3 product from the reaction solvent and 
insoluble NaCl by-product. We had previously followed the original procedure described 
by L. Birkofer and P. Wegner (Org. Synth. 1970, DOI:10.15227/orgsyn.050.0107) using 
dimethyl ethylene glycol solvent, as well as modified versions using other solvents such 
as di-n-butyl ether (Synthesis 1988, DOI: 10.1055/s-1988-27481). We were reproducing a 
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previously reported synthesis (Bioorg. Med. Chem. Lett. 2013, 
DOI: 10.1016/j.bmcl.2013.10.004) using poly(ethylene glycol) (PEG, Mn = 300) as the 
reaction solvent and conducting the reaction at roughly twice the scale described in these 
previous reports (to generate ~200 g of product). 
The reaction mixture had incubated overnight and was being gradually heated in a 
distillation apparatus for the purpose of distilling the trimethylsilyl azide product. We 
observed that magnetic stirring had stopped and that the suspended salts had settled to the 
bottom of the reaction flask. When the student researcher reached into the hood in an 
attempt to adjust the distillation apparatus, the reaction mixture detonated. 
We do not know what caused the explosion, but there are many possible explanations. 
The explosion hazard of azide-containing compounds has been the subject of previous 
safety letters in C&EN and other publications, and many of these warn of the explosive 
hazard of hydrazoic acid that may be generated from proton sources. We used a newly 
opened bottle of PEG as the solvent, and although the supplier data indicated that the 
PEG was dry, PEG itself is protic and can lead to the formation of hydrazoic acid. It is 
also possible that unreacted azide salts that had settled to the bottom of the still were 
overheated to detonation when the stirrer failed. 
Given our accident, and the potential for hazard in the synthesis of TMS-N3, we 
encourage researchers to take special precautions in carrying out any large-scale 
preparation of TMS-N3 by any method. We recommend researchers follow these 
procedures: Reduce the scale of the synthesis so that any possible detonation can 
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reasonably be contained; use mechanical stirring to ensure better heat transfer throughout 
the heterogeneous mixture; and test the apparatus, solvent, and reagents for moisture. We 
are extremely fortunate that the student has recovered from his injuries, but we are also 
convinced that those injuries could have been avoided if these practices had been 
followed in our lab. 
T. Andrew Taton and Walter E. Partlo  
University of Minnesota, Twin Cities” 
   
4.4 Conclusion 
 In this chapter we have detailed our exploration of a variety of methods to 
synthesize many different reductively degradable polymer systems.  Not all of these 
explorations have been fruitful, nor have all of them been investigated as thoroughly as 
we would have liked, but we believe that we have learned much in these explorations, 
and hope that we have adequately conveyed the practical utility of this very interesting 
functional group. 
4.5 Experimental  
4.5.1 2,2-dimethoxyethanol (80). 
 
86 
 
In a 500 mL round bottom flask, MCPBA (27.10 g, 121 mmol) was dissolved into 
methanol (200 mL).  This was cooled to approximately 3 °C in an ice-water bath.  To this 
solution was added ethyl vinyl ether (10.0 mL, 60 mmol) via syringe, over the course of 
30 minutes.  The solution was stirred for 30 minutes, at which time the ice-water bath 
was removed, and the solution stirred overnight at room temperature.  The reaction flask 
was placed on a rotary evaporator for 30 minutes at room temperature and approximately 
300 torr to remove any excess ethyl vinyl ether.  Concentrated sulfuric acid (2.0 mL) was 
added to the flask, and the contents stirred for an additional 2 hours.  Potassium carbonate 
(30.01 g) was added to the flask slowly, and stirring maintained for another 2 hours.  The 
reaction mixture was concentrated by rotary evaporation to remove methanol, then the 
contents diluted in DCM (100 mL).  The contents of the flask were filtered through a 
plug of silica to remove the salts.  The DCM solution was washed 3 times with 5% 
aqueous sodium hydroxide (100 mL), then once with brine (100 mL) and dried over 
anhydrous sodium sulfate.  The solvent was evaporated to yield a clear and colorless oil 
(6.73g, 46 mmol, 77% yield). 
1
H NMR (CDCl3) δ 4.41 (t, 1H), 3.58 (d, 2H), 3.42 (s, 6H). 
4.5.2 Allyl 2,2-dimethoxyethyl ether (81). 
 
To a 500 mL flask was added 150 mL of dry acetonitrile, and 2,2-dimethoxyethanol 
(10.00 g, 94 mmol), then sodium hydride (5.65 g, 141 mmol) portionwise.  Once addition 
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was completed, the mixture was allowed to stir for 10 minutes at room temperature, at 
which time allyl bromide (12.2 mL, 141 mmol) was added.  The reaction was stirred at 
room temperature overnight.  To the reaction flask was added water (150 mL) slowly 
with stirring.  The contents of the flask were extracted with ethyl acetate (3 x 150 mL), 
then the combined organic extracts washed with brine (100 mL), then dried over 
anhydrous sodium sulfate.  The solvent was removed by rotary evaporation to yield allyl 
2,2-dimethoxyethyl ether as colorless oil (12.26 g, 84 mmol, 89% yield). 
1
H NMR 
(CDCl3) δ 5.91 (ddt, 1H), 5.28 (dd, 1H), 5.20 (dd, 1H), 4.52 (t, 1H), 4.03 (d, 2H), 3.48 (d, 
2H), 3.40 (s, 6H). 
4.5.3 2-(Allyloxy)acetaldehyde (76). 
 
To a 250 mL round bottom flask was added allyl 2,2-dimethoxyethyl ether (12.26 g, 84 
mmol), DCM (75 mL) and 10% aqueous hydrochloric acid (75 mL).  This was stirred at 
room temperature for 4 hours.  The flask contents were transferred to a separatory funnel, 
and the layers separated.  The organic layer was dried over anhydrous sodium sulfate.  
The solvent was removed by rotary evaporation to yield 2-(allyloxy)acetaldehyde as a 
colorless oil (5.04 g, 50 mmol, 60 % yield).   
1
H NMR (CDCl3) δ 5.14 (q, 1H), 2.49 (s, 
3H), 1.59 (d, 3H).
  1
H NMR (CDCl3) δ 5.91 (ddt, 1H), 5.28 (dd, 1H), 5.20 (dd, 1H), 4.52 
(t, 1H), 4.03 (d, 2H), 3.48 (d, 2H), 3.40 (s, 6H). 
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4.5.4 2-Azido-diethylene glycol diallyl ether (84). 
 
A dried 100 mL rb flask was flushed with nitrogen, a stir bar and dry acetonitrile (40 
mL), and zinc chloride (0.25 g, 18 nnol) were added.  A septum was affixed, and the flask 
kept under nitrogen overpressure via a balloon.  The flask was stirred and cooled to -40 
°C in a 1:1 water:ethanol dry ice bath.  To the flask was then added 1.0 mL of 2-
(allyloxy)acetaldehyde (1.80 g, 18 mmol), allyloxytrimethylsilane (9.04 mL, 54 mmol), 
and trimethylsilyl azide (3.53 mL, 27 mmol) via syringe.  This was stirred at -40 °C for 2 
hours.  After 2 hours, the reaction mixture was allowed to warm to room temerature, and 
the reaction mixture was then diluted with water (200 mL) in a separatory funnel.  The 
mixture was then extracted with DCM (3 X 50 mL).  The combined organic fractions 
were washed with brine (100 mL), then dried over sodium sulfate, and then the solvent 
evaporated by rotary evaporation to yield 2-azido-diethylene glycol diallyl ether as a 
liquid film (0.20 g, 0.02 mmol, 0.5% yield).   
4.5.5 Diethylene glycol diallyl ether (84). 
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To a 250 mL round bottom flask was added dry THF (100 mL) and sodium hydride 
(10.53 g, 263 mmol).  The mixture was cooled in an ice-water bath to near 0 °C.  To the 
flask was added diethylene glycol (5.0 mL, 53 mmol) and tetrabutyl ammonium bromide 
(5.5 g, 17 mmol) and allyl bromide (22.79 mL, 263 mmol).  The reaction mixture was 
hten stirred for 3 hours at room temperature.  Water (100 mL) was added until all solids 
had dissolved.  The solution was transferred to a separatory funnel, and brine (150 mL) 
was added.  The mixture was extracted with DCM (3 x 150 mL), and the combined 
organic portions were   dried over anhydrous sodium sulfate.  The solvent was removed 
by rotary evaporation to yield diethylene glycol diallyl ether as a colorless oil (9.08 g, 49 
mmol, 92% yield).  
1
H NMR (CDCl3) δ 5.92 (ddt, 2H), 5.28 (ddt, 2H), 5.20 (ddt, 2H), 
4.03 (ddd, 4H), 3.67 (m, 4H), 3.61 (m, 4H). 
4.5.6 Diethylene glycol diglycidyl ether (85). 
 
To a 250 mL Erlenmeyer flast was added DCM (100 mL), diethylene glycol diallyl ether 
(4.29 g, 23 mmol), and MCPBA (15.53 g, 69 mmol).  The heterogeneous mixture was 
stirred at room temperature overnight.  To the flask was added saturated aqueous sodium 
bisulfate (100 mL) slowly, until gas evolution ceased.The reaction mixture was 
transferred to a separatory funnel, awashed with saturated aqueous sodium bicarbonate 
solution (3 x 50 mL), water (2 x 50 mL), and brine (100 mL).  The solution was dried 
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over anhydrous sodium sulfate, and the solvent removed by rotary evaporation to yield 
diethylene glycol diglycidyl ether as a clear oil (5.02 g, 23 mmol, quantitative yield). 
1
H 
NMR (CDCl3) δ 3.80 (dd, 2H), 3.68 (s, 8H), 3.42 (dd, 2H), 3.16 (m, 2H), 2.79 (dd, 2H), 
2.61 (dd, 2H). 
4.5.7 2-bromoactide (93). 
 
To a 250 mL round bottom flask was added benzene (100 mL), lactide (1.02 g, 7 mmol) 
and NBS (1.36 g, 7.6 mmol).  The contents of the flask were stirred and heated to reflux, 
at which time a solution comprising of benzoyl peroxide (34 mg, 0.1 mmol) in benzene 
(10 mL) was added slowly.  The reflux was maintained for 12 hours, then the flask was 
allowed to stir at room temperature over night.  The contents of the flask were transferred 
to a separatory funnel, diluted with ethyl acetate (200 mL), and washed with saturated 
aqueous sodium bisulfate (3 x 100 mL).  The solution was dried over anhydrous sodium 
sulfate, and the solvent removed by rotary evaporation to yield 2-bromolactide as a 
yellow oil that crystallized upon standing (1.36 g, 6 mmol, 87% yield). ).  
1
H NMR 
(CDCl3) δ 5.50 (q, 1H), 2.34 (s, 3H), 1.74 (d, 3H). 
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4.5.8 2-azidolactide (94). 
 
To a 100 mL round bottom flask was added 20bromolactide (0.50 g, 2.2 mmol), acetone 
(50 mL), and sodium azide (0.72 g, 5.6 mmol).  This was stirred over night at room 
temperature.  The flask contents were transferred to a seraratory funnel, diluted with 
diethyl ether (200 mL), washed with water (2 x 100 mL), then brine (100 mL).  The 
solution was dried over anhydrous sodium sulfate, and the solvent evaporated by rotary 
evaporation to yield 2-azidolactide as a viscous brown oil (0.326 g, 1.8 mmol, 80% 
yield).  
1
H NMR (CDCl3) δ 5.14 (q, 1H), 2.49 (s, 3H), 1.59 (d, 3H). 
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